Searching... Searching...
  • NVP -2.99%
  • Köp 1.36
  • Sälj 1.38
  • Senast 1.36
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

Our board

 

David Laskow-Pooley | Chairman (2017)

Born: 1954

Education: BSc Pharmacy (1st), Pharmaceutical/ Chemical engineering specialty and QP., Sunderland School of Pharmacy.

Other assignments: Director of the board of TapImmune Inc, USA, LREsystem Ltd, England and Pharmafor Ltd, England.

No. of shares in NeuroVive: 15 276
Warrants serie 2018:1: 3 819

Other: Non-affiliated to the Company, the management and to major owners.

David Bejker

David Bejker | Director (2017)

Born: 1975

Education: M.Sc. (Econ.), Stockholm School of Economics.

Other assignments: CEO of Affibody Medical AB

No. of shares in NeuroVive: 15 276
Warrants serie 2018:1: 3 819

Other: Non-affiliated to the Company, the management and to major owners.

Anna Malm Bernsten

Jan Törnell | Director (2017)

Born: 1960

Education: MD and PhD in physiology, University of Gothenburg.

Other assignments: Editor-in-Chief for Drug Discovery Today –Disease Models and adjunct Professor at the Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg. Jan is also chairman of the Board at LIDDS AB, Glactone Pharma AB and Glactone Pharma Development AB and Director of the Board at Stayble AB and Diaprost AB, CEO at Oncorena AB and Innoext AB and partner of P.U.L.S. AB.

No. of shares in NeuroVive: 15 276
Warrants serie 2018:1: 3 819

Other: Non-affiliated to the Company, the management and to major owners.

Denise Goode | Director (2018)

Born: 1958

Education: Institute of Chartered Accountants in England and Wales Chartered Accountant. B.Sc. Zoology from The University of Manchester (UK)

Other ongoing assignments:  Director of QED Life Sciences Limited. Director of AnaMar AB.

No. of shares in NeuroVive: –
Warrants serie 2018:1: –

Other: Non-affiliated to the company, the management, and to major owners.